Searched for
ER TABLETS
NPPA fixes retail prices of 23 drug formulationsSimilarly, the retail price of one tablet of Telmisartan, Chlorthalidone & Cilnidipine tablets at Rs 13.17. The retail price of one tablet ...- Granules gets American drug regulator's nod for diabetes management drug MetforminThe US Food and Drug Administration (USFDA) has granted final approval for the company's abbreviated new drug application (ANDA) for Metfor...
- Lupin gets USFDA nod for generic diabetes drugThe company has received tentative approval for the product in multiple strengths from the United States Food and Drug Administration (USFD...
- Granules India gets tentative nod from USFDA for expectorant tabletsGranules India stock was trading at Rs 162.65 apiece, up 2.07 per cent, on the BSE.
- Lupin gets USFDA nod to market its mania and epilepsy treatment drug in USThe company has received approval from the United States Food and Drug Administration (USFDA) for its Divalproex Sodium extended-release ta...
- Wockhardt shares climb 2% after USFDA makes nil observationIn a regulatory filing, the company said no observations were made after the US drug regulator inspected its Bioequivalence centre.
- Lupin launches chronic angina treatment drug in the USThe newly launched product, in strengths of 500 mg and 1,000 mg, is a generic version of Gilead Sciences' Ranexa ER tablets, Lupin said.
- Cipla gets USFDA nod for hypertension, cardiac drugCipla said, Metoprolol succinate extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure, Angina ...
- Lupin launches generic morphine sulfate tablets in USThe company said it has launched the morphine sulfate ER Tablets in strengths of 15 mg, 30 mg, 60 mg, 100 mg and 200 mg having received an ...
- Lupin launches generic diabetes drug in the USLupin has launched 10 products in the US this fiscal year and has received approvals for 21 from the FDA. The drug maker has 35 FTF product...
- Aurobindo Pharma may launch Tramadol tablets in US market from JanuaryAccording to a statement issue by the company, it received final approval from the USFDA to manufacture and market the drug.
- Dr Reddy's Laboratories launches generic drug for Parkinson's treatment in USDr Reddy's Laboratories has launched generic Pramipexole dihydrochloride extended-release tablets for treatment of Parkinson's disease in t...
- Zydus gets USFDA tentative nod to market anti-diabetic tablets"The group now has 97 approvals and has so far filed 249 ANDAs since the commencement of the filing process in 2003-2004."
- Zydus Cadila gets United States Food and Drug Administration nod for kidney stones tabletsZydus Cadila has received the final approval from the USFDA to market Potassium Citrate ER tablets in the strengths of 5 mEq, 10 mEq and 15...
- Aurobindo gets USFDA nod to market mental illness drugAccording to IMS sales data, the product had a market size of around USD 690 million for the twelve months ended March 2014.
- Lupin gets USFDA nod for diabetes drugLupin has received US health regulator's approval to sell its generic version of Glumetza HCl ER Tablets in US market.
- Sun Pharma Advanced Research Company to file new drug application for opthalmic solution in Q2 FY'14Sun Pharma Advanced Research Company (SPARC) today said it plans to file in the second quarter of the next financial year a new drug applic...
- Lupin gets USFDA approval for diabetes drugLupin today said it has received approval from the US health regulator for its Metformin Hydrochloride Extended Release tablets, used in tr...
- Lupin receives USFDA approval for chronic pain drugLupin said it has received approval from the US health regulator to market Tramadol Hydrochloride Extended Release Tablets.
- Sun Pharma gets USFDA nod to market generic Uroxatral tabletsThe company's Alfuzosin Hydrochloride 10-mg tablets are therapeutically equivalent to drug-maker Sanofi-Aventis' Uroxatal extended release ...
Load More
